Meghan Fitzgerald - Dec 3, 2021 Form 4 Insider Report for Pear Therapeutics, Inc. (PEARQ)

Role
Other*
Signature
/s/ Joseph Iannotta as Attorney-in-Fact
Stock symbol
PEARQ
Transactions as of
Dec 3, 2021
Transactions value $
$0
Form type
4
Date filed
12/6/2021, 07:29 PM
Previous filing
Sep 20, 2021
Next filing
May 11, 2022

Meghan Fitzgerald is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

On December 3, 2021, Thimble Point Acquisition Corp. ("THMA" and the former name of the Issuer) consummated an initial business combination (the "Business Combination") with Pear Therapeutics, Inc. The Reporting Person resigned as a director of THMA immediately prior to the consummation of the Business Combination.